MG-132

製品コードS2619

MG-132化学構造

分子量(MW):475.62

MG132 is a potent cell-permeable proteasome and calpain inhibitor with IC50s of 0.1 and 1.2 μM for the inhibition of proteasome and calpain, respectively.

サイズ 価格(税別)  
JPY 8300.00
JPY 28220.00
JPY 78020.00

Selleckは効果が一番いいである(S,R,S)-(-)-2のコンフィギュレーションを採用しましたので、MG-132プロテアソームの抑制効果はSigmaの同類製品の効果より著しく高くなります

正常には、p21蛋白はユビキチン化で分解されますが、MG-132はプロテアソームの活性を抑制することを通じて、p21蛋白の貯まりを引き起こします。だから、MG-132の抑制効果は強ければ強いほど、p21蛋白の貯まりは多くなってきます。(検査された蛋白:p21  細胞株:HeLa细胞株 処理条件:濃度5μM 処理時間:6h)

文献中Selleckの製品使用例(54)

カスタマーフィードバック(11)

  • Western blot of IκBζ expression in BMDMs treated with DI and stimulated with LPS for 1 h. MG132 or bafilomycin A (BafA) were added 30 min before LPS stimulation.

    Nature, 2018, 556(7702):501-504. MG-132 purchased from Selleck.

    MDA-MB-231 cells were treated with 10 uM MG132 and incubated under normoxia or hypoxia for 4 h. Endogenous interaction between LATS2 and SIAH2 was analysed by immunoprecipitation.

    Nat Cell Biol 2015 17(1), 95-103. MG-132 purchased from Selleck.

  • HeLa cells were transfected with control mimic, RMND5A siRNA or miR-138 mimic. After transfection for 36 h, cells were treated with proteasome inhibitor MG132 (20 uM) or Dimethyl sulfoxide (DMSO) for 8 h. Endogenous Exportin-5 protein and RMND5A protein expression was measured by western blotting.

    Nucleic Acids Res 2014 42(1), 458-74. MG-132 purchased from Selleck.

    HeLa cells were transfected with negative control mimic, miR-138 mimic or RMND5A siRNA. After transfection for 36 h, cells were treated with MG132 (20 uM) or DMSO for 8 h. RMND5A and Exportin-5 protein expression were analyzed by immunocytochemistry. Nuclei were counterstained with DAPI.

    Nucleic Acids Res 2014 42(1), 458-74. MG-132 purchased from Selleck.

  •  

    TFEB induced autophagy dependent ATZ clearance in vitro. MEF transiently co-transfected with either ATZ plus GFP expressing plasmids or ATZ plus TFEB expressing plasmids were incubated with proteasome inhibitor MG132 or with DMSO for 6 h. Upon MG132 treatment, steady state levels of 52 kDa ATZ band increased in both cells transfected with ATZ plus GFP and with ATZ plus TFEB expressing plasmids. Quantification of band intensities showed a 48% reduction of ATZ in cells transfected with ATZ plus TFEB compared to cells transfected with ATZ plus GFP, in the absence of the proteasome inhibitor. In MG132 treated cells, a 61% decrease of ATZ was detected in cells transfected with ATZ plus TFEB compared to cells transfected with ATZ plus GFP.

    EMBO Mol Med 2013 5, 397-412. MG-132 purchased from Selleck.

    JAK1 expression was analyzed in A375 cells expressing scrambled shRNA or shRNF125 (#2) and treated with MG132 (5 uM, 10 hr), and in Lu1205 cells expressing WT RNF125 and treated with MG132.

    Cell Rep 2015 11(9), 1458-73. MG-132 purchased from Selleck.

  • LRB1 and LRB2 regulate phyB protein levels. PhyB protein levels in crude extracts from the wild type (WT) and the indicated mutant backgrounds were assayed by immunoblot analysis with anti-phyB monoclonal antibodies. Anti-PBA1 and anti-histone H3 antibodies were used to confirm equal protein loading. Rc-induced loss of phyB in the wild type is inhibited by 100 uM MG132.

    Plant Physiol 2012 60(1), 118-34. MG-132 purchased from Selleck.

    Representative images for γ-H2AX-stained cells treated with 100 uM FA for 3 h without or with MG132. Fluorescence was measured in at least 50 nuclei in each of three experiments.

    Toxicol Appl Pharmacol 2015 286(2), 135-41. MG-132 purchased from Selleck.

  • Nek2A impedes SuFu ubiquitination. HEK293T cells transfected with Nek2A-Myc and Flag-SuFu for 48 h were treated with MG-132 to enrich ubiquitinated proteins, and subsequently subjected to co-immunoprecipitation assay. Precipitated proteins were probed using anti-Ub antibody.

    Int J Oncol, 2017, 50(2):373-380. MG-132 purchased from Selleck.

    GSK-3β phosphorylation at Ser9 is enhanced in NOK-overexpressed stable cell lines. The proteasome inhibitor, MG132, was added in medium of HeLa-HA and HeLa-NOK-HA cells for 12 h and then the p-GSK-3b(Ser9) was assayed by western blotting.

    FEBS Lett 2012 586, 3787–3792. MG-132 purchased from Selleck.

  • Truncated mouse Period2 (Per2) protein was expressed in NIH3T3 cells, treated by cycloheximide with or without MG132 for 1-4 hours.Per2 was reported to be degraded by the proteasome proteolysis. By adding MG132 (25 μM), a proteasome inhibitor, the degradation of Per2 was dramatically decreased within 4 hours treatment (shown by western blot).

    2012 Dr. Edison DUKE-NUS Graduate Medical School Singapore.. MG-132 purchased from Selleck.

質量管理及び製品安全説明書

Proteasome阻害剤の選択性比較

生物活性

製品説明 MG132 is a potent cell-permeable proteasome and calpain inhibitor with IC50s of 0.1 and 1.2 μM for the inhibition of proteasome and calpain, respectively.
ターゲット
20S proteasome [9]
(Cell-free assay)
100 nM
体外試験

MG-132 displays >1000 times more activity than ZLLal in inhibiting the ZLLL-MCA-degrading activity of 20S proteasome with IC50 of 100 nM versus 110 μM. MG-132 also inhibits calpain with IC50 of 1.2 μM. MG-132 induces neurite outgrowth in PC12 cells at an optimal concentration of 20 nM, displaying 500 times more potency than ZLLal. [1] MG-132 (10 μM) potently inhibits TNF-α-induced NF-κB activation, interleukin-8 (IL-8) gene transcription, and IL-8 protein release in A549 cells by inhibition of proteasome-mediated IκBα degradation. [2] MG-132 treatment potently induces p53-dependent apoptosis in KIM-2 cells by 26S proteasome inhibition. [3] Unlike BzLLLCOCHO or PS-341, MG-132 treatment results in weak inhibition of the chymotrypsinlike (CT-L) and peptidylglutamyl peptide hydrolysing (PGPH) activities of the 26S proteasome, whereas multiple myeloma cells (U266 and OPM-2) are more sensitive to induction of apoptosis by MG-132 than BzLLLCOCHO. [4] MG-132 (1 μM) sensitizes TRAIL-resistant prostate cancer cells by activating the AP-1 family members c-Fos and c-Jun, which, in turn, repress the antiapoptotic molecule c-FLIP(L). [5] MG-132 significantly enhances the ability of inositol hexakisphosphate (IP6) to reduce cellular metabolic activity in both PC3 and DU145 androgen-independent prostate cancer (AIPCa) cell lines. [6]

細胞データ
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
LPS-stimulated RAW264.7 cells NXmxWW1KTnWwY4Tpc44hSXO|YYm= MmDpNlUh|ryP MnW5SG1UVw>? Mo\STY5pcWKrdIOgcol1emmlIH;4bYRmKHC{b3T1Z5Rqd25id3n0bEBKSzVyIH;mJFAvOSEQvF2= NVHjc5ZwOjR4OUe0PVY>
HL-60 MlL5R5l1d3SxeHnjJGF{e2G7 MYG0NEDPxE1? MkLBOFghcA>? NWXqRXA5TE2VTx?= M{jaUmlEPTB:MUCg{txO MX6yOFY6PzR7Nh?=
SMMC-7721 NI\Yc2FEgXSxdH;4bYMhSXO|YYm= Mn\kOFAh|ryP NUTVPZFOPDhiaB?= NViyRplpTE2VTx?= NGPEU2FKSzVyPUeuNUDPxE1? MWCyOFY6PzR7Nh?=
A-549 MX\DfZRwfG:6aXOgRZN{[Xl? NGHwbYg1OCEQvF2= NWThXo5[PDhiaB?= M13LbGROW09? NGLHVo1KSzVyPEGwJO69VQ>? NV2yNGZyOjR4OUe0PVY>
MCF-7 MX7DfZRwfG:6aXOgRZN{[Xl? MmfiOFAh|ryP MXS0PEBp M37zU2ROW09? M{K5S2lEPTB;Nz6zJO69VQ>? NXW3dmdNOjR4OUe0PVY>
SW-480 MUHDfZRwfG:6aXOgRZN{[Xl? MYO0NEDPxE1? NYjteIVuPDhiaB?= MVTEUXNQ M3SwV2lEPTB;NDFOwG0> MYOyOFY6PzR7Nh?=
NCI-H929 NEOyfJVEgXSxdH;4bYMhSXO|YYm= M4G0OVEh|ryP MVK3NkBp Mn;tSG1UVw>? MUHJR|UxRTBwMUeg{txO NGrJ[lgzPDZ{NUC4PC=>
293T NGG0SZNEgXSxdH;4bYMhSXO|YYm= MXixNEDPxE1? MUK3NkBp MWLEUXNQ M{PpNmlEPTB:MjFOwG0> NYrCN5d6OjR4MkWwPFg>
293T NVLGcVkxTnWwY4Tpc44hSXO|YYm= NGDucZYyOCEQvF2= NWOxeoNTOjRiaB?= NVLEU2JlTE2VTx?= MUXNc4RmemG2ZXz5JIlv\HWlZYOgbIVifC2|aH;jb{Ah MWGyOFYzPTB6OB?=
HeLa M4jE[mtqdmG|ZTDBd5NigQ>? NWHGZYFKOTBizszN MV:xJIg> NF30[5JFVVOR M4TNfGlv\HWlZYOgVGFTWCClbHXheoFo\SCkeTDpcohq[mm2aX7nJJBzd3OnYYPvcYUh[WO2aY\peJk> NYe1cJhXOjR|MkG4N|M>
MDA-MB-231 NWO1dmRJT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NEi5[lEyKM7:TR?= NF7Kd3c4OiCq M3uyemROW09? NUD5[XVpUUN3ME2wMlE5KM7:TR?= MUOyOFE2OzJyNh?=
MCF-7 NUnJfGNCT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NF[0UFQyKM7:TR?= NU\2ZpJuPzJiaB?= M2\S[2ROW09? NHzUTIFKSzVyPUCuNVMh|ryP MYGyOFE2OzJyNh?=
MCF10A MnfMS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M2SwS|Eh|ryP NUHtenRQPzJiaB?= MlPtSG1UVw>? Ml\0TWM2OD1yLkK5JO69VQ>? M3G4R|I1OTV|MkC2
HEK-293 MYDLbY5ie2ViQYPzZZk> NX7xcmRMOiCjbnSgNlAh|ryP NGjTUmQzKGh? NHzMZodFVVOR MUXJcohq[mm2czDDbHQuVCCjY4Tpeol1gSC5aYToJGlEPTBib3[gPUBvVSB? M3LmTVI{PTRyN{mw
Calu6 NInFcWdHfW6ldHnvckBCe3OjeR?= MX6xNEDPxE1? MorwNVghcA>? NW\RU|ZHTE2VTx?= NWOwZ3p7W2mpbnnmbYNidnSueTDhZ4N2dXWuYYTld{BnemG2YYjpckBxemWldYLzc5I> M3fYSlI{PTB4NEi2
IFN-gamma-induced RAW264.7 NHvROZdHfW6ldHnvckBCe3OjeR?= NEKzVIRFVVOR NEPpeXhKdmirYnn0d{BvcXS{aXOgc5hq\GVicILv[JVkfGmxbjD3bZRpKEmFNUCgc4YhOC5yN{eg{txO M2LR[lIzOjd5Mke3
IPC227F NXLMWVFnS3m2b4TvfIlkKEG|c3H5 NWfWS|JvOSEQvF2= NGPQOJU1QCCq M2n1TWROW09? NX;UXW9xUUN3ME2wMlA4PyEQvF2= M{fNdVIyQTJ2NUK4
Hepa-1c1c7 NYrK[WNCTnWwY4Tpc44hSXO|YYm= NEj5cmQzPSEQvF2= MUe2JIg> Mmf3SG1UVw>? MoTKTY5kemWjc3XzJG5z\jJicILveIVqdiCuZY\lcC=> NFzn[VMzODN7MkW0OC=>
COS-7 MUTDfZRwfG:6aXOgRZN{[Xl? NVnVbnFwOTBizszN NXTKeJdLTE2VTx?= M3zON2lEPTB:MUCg{txO M3jKNVE5ODh6MEm3
HuH-7 MojjR5l1d3SxeHnjJGF{e2G7 NID2TWMyOCEQvF2= M2HWO2ROW09? MXvJR|UxRDFyIN88US=> MlnTNVgxQDhyOUe=
OCI-Ly3 NFX5RnRHfW6ldHnvckBCe3OjeR?= M3rPVFExKM7:TdMg MoLmOEBp NELwRpBFVVOR Mnq2TY5lfWOnczDoeY1idiCLa3HwdIFD[WyyaHGgd5Ri[mmuaYrheIlwdiC5aYToJGVEPTBib3[gNUDPxE1? NHjxSZkyQDB{NEGxNy=>
A2780 cDDP M33lfWFxd3C2b4Ppd{BCe3OjeR?= MmDoNlQhcA>? M3rZ[GROW09? M1ywbGlv\HWlZYOgZZBweHSxc3nzJIJ6KGmwaHnibZRqdmdiUGTFUkBl\We{YXTheIlwdg>? NVTZ[4JXOTd4OESwNVg>
LPS-stimulated RAW264.7 cells NV63OpVHTnWwY4Tpc44hSXO|YYm= MXPEUXNQ MWrJcohq[mm2czDOSk1s[XCyYVKgSG5CKGKrbnTpcoc> MnLMNVc1ODd{N{e=
PC12 NU\kXmE2TnWwY4Tpc44hSXO|YYm= NFL1OIMyODBizszNxsA> NIfUOo0zPCCq MWLEUXNQ MYrJcohq[mm2czC2MW9JTEFvIHHu[EBJOk9{LXnu[JVk\WRiY4n0c5RwgGmlaYT5 MoHMNVcyPTh2NUS=
PC3 MmmxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MYiyNEDPxE1? MnG2OFghcA>? NXPPSnRzTE2VTx?= MmPVTWM2OD1yLk[g{txO M2DHT|E3Pjh4NUO3
LP-1 NVy2ZZFsSXCxcITvd4l{KEG|c3H5 NYnJW|BqOzByIH7N MnztNlQhcA>? MWHEUXNQ NEnaWFZKdmS3Y3XzJIFxd3C2b4Ppd{BjgSCrbnPy[YF{cW6pIHPs[YF3\WRiUFHSVEBt\X[nbDDhcoQhemWmdXPpcochVWOuLUGgdJJwfGWrbjDs[ZZmdA>? MljuNVU6PTh3OEm=
ES6 NE\rW2NIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NEHMV4hKSzVyPUCuNFE{ODZizszN Ml\rV2FPT0WU
A101D MkC3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NXz4XIRrUUN3ME2wMlA{Ojd7IN88US=> MVLTRW5ITVJ?
OCUB-M M{n6U2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MXHJR|UxRTBwMEO3N|ch|ryP NWqyPJBlW0GQR1XS
LB2518-MEL MVjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NH\vW4ZKSzVyPUCuNFM4PiEQvF2= M2flWXNCVkeHUh?=
SH-4 M4qxfGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MkjzTWM2OD1yLkC0N|Eh|ryP MX;TRW5ITVJ?
KNS-42 NHvMUodIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NV\qNopwUUN3ME2wMlA1PDRzIN88US=> M3WwN3NCVkeHUh?=
DSH1 NUfJeW5uT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M2fpZ2lEPTB;MD6wOVI5QSEQvF2= MoDqV2FPT0WU
NTERA-S-cl-D1 NF;jVW5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M4rHS2lEPTB;MD6wOVc4OiEQvF2= M{K2cXNCVkeHUh?=
D-542MG NWPpTWZsT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MX7JR|UxRTBwMEW5OVch|ryP MWnTRW5ITVJ?
KS-1 MlHBS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NWrlZ4pLUUN3ME2wMlA3PDV6IN88US=> NY\mVnlFW0GQR1XS
BL-41 M3;iUmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M4PXN2lEPTB;MD6wOlk1PyEQvF2= NEjjZ5VUSU6JRWK=
LXF-289 NFjLblRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MWfJR|UxRTBwMEewOlYh|ryP M1T1UXNCVkeHUh?=
D-247MG NVzTOnFTT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NHixU3pKSzVyPUCuNFczODlizszN M2HjZ3NCVkeHUh?=
MMAC-SF MXTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MlzPTWM2OD1yLkC3NlY5KM7:TR?= MlHOV2FPT0WU
CP66-MEL MlTKS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M2D5Z2lEPTB;MD6wO|Uh|ryP MYLTRW5ITVJ?
LB771-HNC NHPvcJhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M3[wc2lEPTB;MD6wPFA{PiEQvF2= NVrXSG5LW0GQR1XS
no-10 NHfoTm5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MVjJR|UxRTBwMEi5NFkh|ryP MmHWV2FPT0WU
A388 MX;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NU[4eWlmUUN3ME2wMlA6ODZ3IN88US=> MXjTRW5ITVJ?
OPM-2 MUjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NGfKbnlKSzVyPUCuNVA1PzRizszN NF36RY1USU6JRWK=
OVCAR-4 NYf5fHR4T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NV7PNnl5UUN3ME2wMlExQTN6IN88US=> MXnTRW5ITVJ?
HOP-62 MYfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MXjJR|UxRTBwMUC5OFkh|ryP NWDFVZEyW0GQR1XS
ML-2 MV\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NGW5fZVKSzVyPUCuNVE5ODZizszN M1vpfHNCVkeHUh?=
UACC-257 MV\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NHLlSlhKSzVyPUCuNVE6OjdizszN MULTRW5ITVJ?
NEC8 M2TJdWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 Mm\wTWM2OD1yLkGxPVk2KM7:TR?= M1zhfnNCVkeHUh?=
ONS-76 NGrUToRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MV3JR|UxRTBwMUK5N|Uh|ryP NYnlOJNJW0GQR1XS
KE-37 M4eySmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MWPJR|UxRTBwMUOyO|gh|ryP NHvlZXRUSU6JRWK=
HT-144 M3;xUmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MkiwTWM2OD1yLkGzPFk2KM7:TR?= MXjTRW5ITVJ?
LB2241-RCC MYfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NETadlJKSzVyPUCuNVQzPDdizszN NGPqZW5USU6JRWK=
TE-5 NGGxdXpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MV\JR|UxRTBwMUSyO|gh|ryP NYG1N4ZSW0GQR1XS
KINGS-1 NFHaZXJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M3m1c2lEPTB;MD6xOFc6KM7:TR?= MoHHV2FPT0WU
NCI-H69 MX3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MUXJR|UxRTBwMUWxOFEh|ryP NXLBbZhiW0GQR1XS
CAS-1 NVfCVlZ1T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MnnlTWM2OD1yLkG1OFgzKM7:TR?= NWTLXWVJW0GQR1XS
D-263MG Mn\zS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NF;ZNlJKSzVyPUCuNVYxODZizszN MWfTRW5ITVJ?
A253 MnjYS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MVvJR|UxRTBwMU[xNlgh|ryP NYHDPFd5W0GQR1XS
PF-382 NEf3UINIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MXjJR|UxRTBwMU[3NFYh|ryP Ml64V2FPT0WU
CESS MmjES5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MlnkTWM2OD1yLkG3NFYh|ryP M3OwXXNCVkeHUh?=
MZ2-MEL MYnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MWHJR|UxRTBwMUe1OVkh|ryP M3PXdHNCVkeHUh?=
HEL NV25OmhjT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M121cmlEPTB;MD6xPFUyPyEQvF2= Ml7MV2FPT0WU
D-392MG NEHacmJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MkPLTWM2OD1yLkG5NVE2KM7:TR?= NHz2PXRUSU6JRWK=
SK-LMS-1 MmjOS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NVviT49ZUUN3ME2wMlE6OzB|IN88US=> MWLTRW5ITVJ?
GI-ME-N NXXDV4w3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M{HoUGlEPTB;MD6xPVMxPiEQvF2= NEHqT4ZUSU6JRWK=
LB831-BLC MYfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NXryW5U5UUN3ME2wMlE6OzRizszN NHXWcmNUSU6JRWK=
DU-4475 M36w[mdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MlWzTWM2OD1yLkG5OlU5KM7:TR?= NYrTS|BsW0GQR1XS
IST-SL1 MXLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MnvoTWM2OD1yLkKwNFk1KM7:TR?= MnnXV2FPT0WU
GAK MXTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NGfDS3BKSzVyPUCuNlA2OzRizszN M{mwU3NCVkeHUh?=
EW-1 NGizeZVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MXjJR|UxRTBwMkGwOFch|ryP NYjlTVVzW0GQR1XS
LAMA-84 MkDjS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MnL4TWM2OD1yLkKxPFUyKM7:TR?= MnLnV2FPT0WU
SK-UT-1 MUnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MWjJR|UxRTBwMkKwOFkh|ryP MmruV2FPT0WU
VA-ES-BJ NUHYfWxtT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MlHSTWM2OD1yLkKyNlU4KM7:TR?= MlKwV2FPT0WU
ACN MWrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NILGeGRKSzVyPUCuNlI3OzhizszN MYrTRW5ITVJ?
SK-PN-DW MXXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NXvYcoxuUUN3ME2wMlI{OTlizszN MWHTRW5ITVJ?
HD-MY-Z NWW0eZVtT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MYXJR|UxRTBwMkOzNFMh|ryP NUP0dGZFW0GQR1XS
LB373-MEL-D M3Lvdmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MkH0TWM2OD1yLkK0NVk5KM7:TR?= M1PuR3NCVkeHUh?=
COLO-829 MVvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MVrJR|UxRTBwMkSyOVch|ryP NWnvcXVMW0GQR1XS
ES8 Mmr2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MVPJR|UxRTBwMkS3OlMh|ryP MU\TRW5ITVJ?
RXF393 NYTCeFRtT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M37KZWlEPTB;MD6yOVAyPSEQvF2= MYrTRW5ITVJ?
TK10 MVzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M{HsNWlEPTB;MD6yOVQ{PSEQvF2= NUnlN45uW0GQR1XS
LOUCY NVntemg6T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MXnJR|UxRTBwMkW0OVYh|ryP M{W0PHNCVkeHUh?=
MZ7-mel MXTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NYrRfI9PUUN3ME2wMlI3Ozd2IN88US=> NGi4OnlUSU6JRWK=
CP67-MEL MUfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M3zQRmlEPTB;MD6yOlc{KM7:TR?= NXjTd5FUW0GQR1XS
C2BBe1 NH7wUW9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NEiwdJlKSzVyPUCuNlc6ODdizszN NFfHcZZUSU6JRWK=
K052 Mn\kS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MWjJR|UxRTBwMki5PUDPxE1? MlnJV2FPT0WU
MOLT-16 MXnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MYPJR|UxRTBwMkm1NlQh|ryP MXjTRW5ITVJ?
KNS-81-FD Mm\NS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M1HMRWlEPTB;MD6zNFMzOyEQvF2= MXTTRW5ITVJ?
CMK MoXRS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NUnnU2t{UUN3ME2wMlMyOTJizszN M1HzPHNCVkeHUh?=
LAN-6 MULHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NFzIbnFKSzVyPUCuN|E{KM7:TR?= M4rWNHNCVkeHUh?=
KLE NX21Ro17T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MU\JR|UxRTBwM{GzNFYh|ryP NV3yeGtYW0GQR1XS
NCCIT MlHVS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NU\BRnI4UUN3ME2wMlMyPzh|IN88US=> M3L1[XNCVkeHUh?=
HH NGPFW2hIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M{H3c2lEPTB;MD6zNlg6PyEQvF2= NHrCVINUSU6JRWK=
TE-8 M2Xoemdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NIe0TZhKSzVyPUCuN|QzPzlizszN NVXtVpQ1W0GQR1XS
GDM-1 M2PnZmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MnTZTWM2OD1yLkO1NVA1KM7:TR?= MlXTV2FPT0WU
NCI-H747 M1HNTmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MlnjTWM2OD1yLkO3NVA{KM7:TR?= MoHSV2FPT0WU
NCI-H1092 MVzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MUHJR|UxRTBwM{i4OFQh|ryP MV;TRW5ITVJ?
8-MG-BA NX7F[4lrT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MXLJR|UxRTBwM{m4N|ch|ryP MnLZV2FPT0WU
NB17 NV;zd4h4T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M{O3cWlEPTB;MD60Nlk4KM7:TR?= NX7VSWZNW0GQR1XS
LC4-1 MnG4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NUfmV4xRUUN3ME2wMlQ{PjB5IN88US=> NYPCZpBvW0GQR1XS
TE-1 NUjyWnE3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NYTpOFl2UUN3ME2wMlQ2OTF7IN88US=> NXLrPINMW0GQR1XS
KALS-1 MnzNS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NXrFbnI3UUN3ME2wMlQ3PTh2IN88US=> MnrkV2FPT0WU
CCRF-CEM MY\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MXTJR|UxRTBwNEe2O|Qh|ryP NFHJcYFUSU6JRWK=
OS-RC-2 MnTnS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M{j3RmlEPTB;MD60O|k4OiEQvF2= MnLYV2FPT0WU
A704 M2jQNmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MYXJR|UxRTBwNEi2PVIh|ryP NXq3SG9ZW0GQR1XS
BB49-HNC MYnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NYD3[m5EUUN3ME2wMlQ6ODl4IN88US=> MonWV2FPT0WU
EVSA-T M4HLR2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M1\pU2lEPTB;MD60PVkyOSEQvF2= NU\NeotFW0GQR1XS
Mo-T MXfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NHv4cmJKSzVyPUCuOVE4PjJizszN NH;VWm1USU6JRWK=
MONO-MAC-6 MUDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? Ml7DTWM2OD1yLkWzOlEyKM7:TR?= MmL6V2FPT0WU
BB65-RCC M4jPUmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MlXVTWM2OD1yLkW2PFEyKM7:TR?= MYfTRW5ITVJ?
NCI-H1882 MnXHS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NEfW[Y1KSzVyPUCuOVkxOzZizszN MWXTRW5ITVJ?
TE-9 M3TWNWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NUPVXWZiUUN3ME2wMlYyODN|IN88US=> M4raenNCVkeHUh?=
NCI-H2126 M33JZmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M4CzNmlEPTB;MD62NlY3QSEQvF2= MnHIV2FPT0WU
SF268 MnPsS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NHrjS4JKSzVyPUCuOlU3PDFizszN M3O1ZXNCVkeHUh?=
SW872 M1nBT2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MXjJR|UxRTBwNkW3Nlkh|ryP NUP1Z2Z4W0GQR1XS
LS-513 M1\NcGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NUe1eFJoUUN3ME2wMlY3PzVzIN88US=> M2DKOHNCVkeHUh?=
NCI-H1355 NYXTd2s4T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MmjNTWM2OD1yLk[4OlE6KM7:TR?= NUftUWlQW0GQR1XS
BL-70 M{X4fWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NX3tfnRCUUN3ME2wMlY6Ozh6IN88US=> Mmn0V2FPT0WU
NCI-SNU-5 M2nnS2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MkW1TWM2OD1yLk[5OVQ2KM7:TR?= MX\TRW5ITVJ?
SNU-C2B NVPqXGlvT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NVi0do5CUUN3ME2wMlcxPzN7IN88US=> NVHRXVRsW0GQR1XS
GB-1 MYfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MX3JR|UxRTBwN{KxNlQh|ryP NEnyT3hUSU6JRWK=
CTB-1 NFf0b4pIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NGPvNFVKSzVyPUCuO|c6PTVizszN MnSzV2FPT0WU
Becker M1LKN2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NXvKTIl{UUN3ME2wMlc6PjJzIN88US=> NV\k[lFiW0GQR1XS
KM12 M37XSmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NHfLZo1KSzVyPUCuPFU1PjZizszN MVHTRW5ITVJ?
ES7 MmrpS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NXLrNFBjUUN3ME2wMlg6PjVizszN MYLTRW5ITVJ?
COLO-684 MYjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MkCyTWM2OD1yLkmwOlU5KM7:TR?= MlvFV2FPT0WU
HCC2998 NVTi[mVWT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NWnvZXY5UUN3ME2wMlk{QDV2IN88US=> Mor1V2FPT0WU
TE-10 NIH4WnlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= Mn7uTWM2OD1yLkm2OFMh|ryP NWXGOmhWW0GQR1XS
SF126 NInR[ZdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NVnibIp[UUN3ME2wMlk5QTdzIN88US=> MkLHV2FPT0WU
EKVX NH\JWoZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NX;nTotWUUN3ME2xMlA{PDR{IN88US=> M4rwfHNCVkeHUh?=
KARPAS-45 MVTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NYGzUmpqUUN3ME2xMlA1ODF4IN88US=> MWrTRW5ITVJ?
KGN MlrwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M2X4PWlEPTB;MT6wOVA1PSEQvF2= MkXKV2FPT0WU
ES1 NXjVR4ZiT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M323eGlEPTB;MT6wO|kzOSEQvF2= NWL4SGJ3W0GQR1XS
L-540 M1Wy[mdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NUK2OGx[UUN3ME2xMlEyQDN7IN88US=> NEG3OWJUSU6JRWK=
KURAMOCHI M33jdGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MXnJR|UxRTFwMUKzO|Qh|ryP MnH2V2FPT0WU
LU-65 NWe1RZpXT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NUGxPI83UUN3ME2xMlEzPzV|IN88US=> NIS4OoRUSU6JRWK=
MFH-ino NGLwT|NIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NH\iVlVKSzVyPUGuNVc2ODFizszN MWjTRW5ITVJ?
NCI-H23 NGG3bllIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NV;UT4ppUUN3ME2xMlIxPDFizszN MX;TRW5ITVJ?
IA-LM NHPmeVJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MYPJR|UxRTFwMkSxNVYh|ryP NGDsRXRUSU6JRWK=
PSN1 NFn6TlhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MVnJR|UxRTFwMkewNVYh|ryP NF7jeIdUSU6JRWK=
NCI-H719 MWnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MYrJR|UxRTFwMke0NVEh|ryP NUTwT|N7W0GQR1XS
SW684 NWH3U2VmT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M3LuUGlEPTB;MT6yPFY2QSEQvF2= NILKS2pUSU6JRWK=
HCE-4 MVXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M2[xd2lEPTB;MT6zNFIzOSEQvF2= M2TsZXNCVkeHUh?=
EW-16 NGjn[YxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MYLJR|UxRTFwM{GzOFch|ryP M3HyOnNCVkeHUh?=
NCI-H128 M2LmVWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MmeyTWM2OD1zLkO1PFE1KM7:TR?= MnLPV2FPT0WU
HC-1 NFLVWZVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MULJR|UxRTFwM{ixO{DPxE1? NVPmZ5BuW0GQR1XS
IST-MES1 M3P6b2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NV;SR3dXUUN3ME2xMlQxOjB6IN88US=> NXTyflNRW0GQR1XS
Raji NEjEO|hIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MVTJR|UxRTFwNEG4OUDPxE1? NIPxRYFUSU6JRWK=
DMS-114 NIjrcm5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MknaTWM2OD1zLkS0OVM6KM7:TR?= NHzzSVZUSU6JRWK=
GI-1 MW\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NEDCWGlKSzVyPUGuOFcyOzFizszN NVT6TZczW0GQR1XS
NCI-H2081 M1zkc2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NFu2Wm9KSzVyPUGuOVUyQTZizszN NFnxfoFUSU6JRWK=
LC-1F MXXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M3vHdWlEPTB;MT61OVE6QCEQvF2= NYraS3ZZW0GQR1XS
NCI-H2227 M2Dic2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MmDsTWM2OD1zLk[xOVYyKM7:TR?= NHPXdJFUSU6JRWK=
D-502MG MmDmS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NXrSOYxFUUN3ME2xMlY4OjFzIN88US=> MUjTRW5ITVJ?
NCI-H2141 NFH5NJRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MWPJR|UxRTFwNkezNVch|ryP Ml\XV2FPT0WU
LS-411N M3exXWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NXe2XGxvUUN3ME2xMlY6QDB5IN88US=> NF7G[ZFUSU6JRWK=
SU-DHL-1 MVHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M36yNGlEPTB;MT63NVI5OSEQvF2= Mn:zV2FPT0WU
BB30-HNC M3;kRWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NFroc5VKSzVyPUGuO|I3QDVizszN M3LvT3NCVkeHUh?=
TE-15 M3PWRWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NXeyb4tTUUN3ME2xMlkzOzd|IN88US=> NXH6WJBZW0GQR1XS
JVM-3 M4jE[mdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NHHVZZZKSzVyPUGuPVM6ODRizszN NFi1fpZUSU6JRWK=
IST-SL2 M3jGNGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MWrJR|UxRTJwMEGyOVIh|ryP NXHEcohzW0GQR1XS
EW-18 MkPZS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MYHJR|UxRTJwMEKzN|ch|ryP NF\ifZFUSU6JRWK=
DJM-1 MnzuS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MVLJR|UxRTJwMEK1OVIh|ryP MXPTRW5ITVJ?
no-11 MUnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NX;VOFF3UUN3ME2yMlA{OTB2IN88US=> M1TVXXNCVkeHUh?=
QIMR-WIL M{jNbGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NF;R[pFKSzVyPUKuNVY4PjJizszN Mn7sV2FPT0WU
MC-CAR M4HvV2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NW\tdlJlUUN3ME2yMlIzQTVizszN MWHTRW5ITVJ?
KM-H2 Moj2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MVHJR|UxRTJwMkmwOFMh|ryP Ml\PV2FPT0WU
ECC12 NFTvdHBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NITJZ2FKSzVyPUKuN|c6PCEQvF2= NH;SWlhUSU6JRWK=
HCE-T MofzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? Mn7JTWM2OD1{LkS0PFg{KM7:TR?= MUHTRW5ITVJ?
MFM-223 NYrWdXlVT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MUfJR|UxRTJwNUC4O|Eh|ryP MkfzV2FPT0WU
SW982 M2rOeGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 Mon6TWM2OD1{LkWxOFgh|ryP NVPHSGtpW0GQR1XS
KG-1 NXzRZ3R7T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M1ryTGlEPTB;Mj64PFc6OSEQvF2= MWnTRW5ITVJ?
ES4 NEXldFhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MlPOTWM2OD1|LkC2NVEyKM7:TR?= NHP6WpFUSU6JRWK=
SCC-3 MWTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MkT0TWM2OD1|LkGwPFQ5KM7:TR?= MWrTRW5ITVJ?
RH-1 NV3iUoRxT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NIfqPIRKSzVyPUOuN|g4PDhizszN M1nqfXNCVkeHUh?=
NCI-H748 MUHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MXXJR|UxRTNwNESyOlYh|ryP NGr5UJVUSU6JRWK=
HCC2218 M33JNmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NGXESFRKSzVyPUOuOFY6OzdizszN NIjLWlZUSU6JRWK=
MEG-01 NWTYbnN5T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MlXRTWM2OD1|LkW5Olgh|ryP M1H3fXNCVkeHUh?=
NB12 NFjQbXJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NHfPZnJKSzVyPUOuOVk5QDhizszN Mn3nV2FPT0WU
SNB75 NViwTHFXT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MVfJR|UxRTNwNkCxNFMh|ryP M1HTeHNCVkeHUh?=
KMS-12-PE NUXSeoJsT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NGf4U5RKSzVyPUOuOlc4OjNizszN NYnnbItTW0GQR1XS
SKM-1 NIPydG5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MmPFTWM2OD1|LkexN|c3KM7:TR?= MnXyV2FPT0WU
COLO-320-HSR M1PlbWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MkXMTWM2OD1|Lke1OlM1KM7:TR?= MUPTRW5ITVJ?
NKM-1 NHu0SFdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M1[yRWlEPTB;Mz63O|M4QCEQvF2= MmLHV2FPT0WU
TE-6 MYXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NHnZeYlKSzVyPUOuPVQ2PjFizszN Mmq3V2FPT0WU
D-336MG NUXVfIdbT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NVryclJnUUN3ME20MlAyOTZ4IN88US=> NU\TTnRuW0GQR1XS
NCI-H1650 NX60bnJPT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M4XsTWlEPTB;ND6xOVc6PyEQvF2= Mo[wV2FPT0WU
ES3 NFy5WG9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MVvJR|UxRTRwM{K4NlQh|ryP NEn3cJBUSU6JRWK=
YT NFXweoZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= Ml7TTWM2OD12LkO1OFI1KM7:TR?= Ml7GV2FPT0WU
ES5 NFXyeGFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MYjJR|UxRTRwNECyOVUh|ryP Mlr3V2FPT0WU
LB647-SCLC NEPmPZlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NFLsWpBKSzVyPUSuOVY{ODhizszN MV;TRW5ITVJ?
HAL-01 M1ftWWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MXTJR|UxRTRwNUewN|Qh|ryP M4LKW3NCVkeHUh?=
LP-1 NIn3UHRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NV3EWW9GUUN3ME20MlczOzdzIN88US=> MWDTRW5ITVJ?
BC-1 MUTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MYDJR|UxRTVwMEC0OFch|ryP M1rhcnNCVkeHUh?=
EB-3 NEX6TmRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NGHje3lKSzVyPUWuNFMxPDFizszN NE\ScGpUSU6JRWK=
GT3TKB Ml75S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MkHRTWM2OD13LkG3OlYzKM7:TR?= M1K3WXNCVkeHUh?=
NCI-H209 M3rCVGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M2mwOGlEPTB;NT6xPVM2OiEQvF2= M1ftXXNCVkeHUh?=
BT-474 MVrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M1qwOWlEPTB;NT6yN|ExOiEQvF2= NGHjPYlUSU6JRWK=
RKO M{fRW2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NYTLWm9zUUN3ME21MlI{PDJ{IN88US=> M4G4WnNCVkeHUh?=
SIMA M13r[2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M2Tke2lEPTB;NT6zNFc3PSEQvF2= M{TYXXNCVkeHUh?=
RL MmDoS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MorVTWM2OD13LkO3OVQyKM7:TR?= MW\TRW5ITVJ?
GCIY M13xeWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MoWwTWM2OD13LkS3NlM3KM7:TR?= MYDTRW5ITVJ?
Calu-6 Moi3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NXPRfVlOUUN3ME21MlYzOiEQvF2= M3m1O3NCVkeHUh?=
ALL-PO M37VdWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M3u2PGlEPTB;NT62N|c6PSEQvF2= NVXTcXh6W0GQR1XS
ARH-77 MorzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M3T2O2lEPTB;NT62O|A5PyEQvF2= MWXTRW5ITVJ?
A4-Fuk Mm\sS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MmD4TWM2OD14LkC4NVE5KM7:TR?= MnPSV2FPT0WU
NCI-H1581 NHjR[3lIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NYTDPG03UUN3ME22MlI{QDR7IN88US=> MmTwV2FPT0WU
HUTU-80 NFP4VGpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NFfZPXRKSzVyPU[uN|Y5QTdizszN M4PTXnNCVkeHUh?=
TGW NYXxNXpvT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NYCxOZNNUUN3ME22MlQ2PTl|IN88US=> M3[xcnNCVkeHUh?=
SK-N-FI M1LhRmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M4j4Z2lEPTB;Nj60OVg2PCEQvF2= M2DlTXNCVkeHUh?=
U-266 NVvPZoNUT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NWXBRWx4UUN3ME22MlUyQTJ4IN88US=> NWTofWNEW0GQR1XS
EM-2 MmjjS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MkHYTWM2OD14Lk[3NFk6KM7:TR?= MWnTRW5ITVJ?
NMC-G1 MnWyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NYi2R2trUUN3ME22MlcyQDl3IN88US=> MVPTRW5ITVJ?
KASUMI-1 MWfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NVT6RmtLUUN3ME22Mlg1Pzh5IN88US=> MWHTRW5ITVJ?
NALM-6 M{X5fmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NVu5NlcxUUN3ME22Mlg3PzV2IN88US=> NF\KW2dUSU6JRWK=
OCI-AML2 MWHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M{\Ye2lEPTB;Nz6wNFMzPiEQvF2= MYTTRW5ITVJ?
SHP-77 MmPqS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NX\VOY9pUUN3ME23MlIzPDNizszN M4jtT3NCVkeHUh?=
NOMO-1 Mmq0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? Mn22TWM2OD15LkK0NlU1KM7:TR?= MWfTRW5ITVJ?
SK-N-DZ MlfHS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MUfJR|UxRTdwN{GwPFkh|ryP M4DnR3NCVkeHUh?=
LB1047-RCC M4\TWWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NIDRTW9KSzVyPUeuO|IzOzFizszN M2e2dHNCVkeHUh?=
MZ1-PC MVXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NHj6S2ZKSzVyPUeuPFY2PThizszN M4\CeHNCVkeHUh?=
NB10 M{\ZUGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NEjGOoNKSzVyPUeuPVk2PTZizszN M2nmSnNCVkeHUh?=
RL95-2 NVrrfohsT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MYTJR|UxRThwMUC4OFIh|ryP MmnXV2FPT0WU
OMC-1 MkiwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MYfJR|UxRThwNUKxPVEh|ryP NIizdWZUSU6JRWK=
D-283MED NVXDZndYT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M3fOb2lEPTB;OD65NVcyQSEQvF2= MXnTRW5ITVJ?
MC116 M2jmUGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NVy5SXVkUUN3ME24Mlk4QTRizszN M4W4UHNCVkeHUh?=
SJSA-1 MXTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MoG0TWM2OD17LkC5NFkyKM7:TR?= NHnncHJUSU6JRWK=
JiyoyeP-2003 NE\3fm5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NH70W2hKSzVyPUmuNlk{OTdizszN M{W2cHNCVkeHUh?=
IST-MEL1 NVW0V4R2T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M4XNcmlEPTB;OT63OFE6QCEQvF2= NI[0e3BUSU6JRWK=
CTV-1 MUPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MoPaTWM2OD1zMD6wPVc6KM7:TR?= NX\0NYNmW0GQR1XS
NH-12 MnrwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NGXmPYtKSzVyPUGwMlI1OzNizszN NEPi[nNUSU6JRWK=
CA46 MoTyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M4jHSWlEPTB;MUCuN|YyKM7:TR?= MkHKV2FPT0WU
NCI-SNU-1 MWTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NIjqdohKSzVyPUGwMlQ6PjlizszN MYHTRW5ITVJ?
SCLC-21H NVrE[VJ6T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NGH6UG5KSzVyPUGwMlY2QTZizszN MYfTRW5ITVJ?
EC-GI-10 MlXHS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MmfOTWM2OD1zMD63NFMyKM7:TR?= NWK1[mhMW0GQR1XS
SR MmrHS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NWnzZ3lWUUN3ME2xNU4xOTh3IN88US=> MVLTRW5ITVJ?
NCI-H1648 MYrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NEjvfGpKSzVyPUGxMlA6PjVizszN MYrTRW5ITVJ?
TGBC1TKB M2j3Nmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MoXVTWM2OD1zMT60NVAzKM7:TR?= NIj2N3lUSU6JRWK=
EW-11 NVjkfIJLT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M2H3V2lEPTB;MUGuOVE5PiEQvF2= NH\aV3BUSU6JRWK=
SK-MM-2 NIjVVIZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M1rlWmlEPTB;MUGuPFA3OSEQvF2= Mkf0V2FPT0WU
NCI-H524 NG\FdVNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MnXaTWM2OD1zMT65PFIzKM7:TR?= MonwV2FPT0WU
NOS-1 MXvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M2jhcGlEPTB;MUKuNFM1PSEQvF2= NF3oTHZUSU6JRWK=
AM-38 MlzpS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NVTlZ4tVUUN3ME2xNk42PjN|IN88US=> NVnrSZplW0GQR1XS
A498 NH3CXFFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MnTyTWM2OD1zMj63NFY6KM7:TR?= NFHNPXJUSU6JRWK=
KARPAS-422 NIroR3pIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= Mlv4TWM2OD1zMj63OFk3KM7:TR?= MUXTRW5ITVJ?
LU-139 MlHsS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? Mki0TWM2OD1zMj65NFI3KM7:TR?= M1H0U3NCVkeHUh?=
COR-L88 NWn0e28{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MlLnTWM2OD1zMj65N|gzKM7:TR?= M3PlVHNCVkeHUh?=
K5 M1;UUWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MVHJR|UxRTF{Lkm0OlIh|ryP NHXDUpFUSU6JRWK=
NB13 NVnzPFllT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M2TEdWlEPTB;MUKuPVc5OyEQvF2= NEDBc4lUSU6JRWK=
MRK-nu-1 MnLuS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M1L3cWlEPTB;MUOuNVk2KM7:TR?= NHnZbmRUSU6JRWK=
MHH-NB-11 M2DGU2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M161U2lEPTB;MUOuNlkxOiEQvF2= Mn3KV2FPT0WU
KU812 M1XlfGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MnrSTWM2OD1zMz62NVI1KM7:TR?= M4XNVHNCVkeHUh?=
TE-12 M2DWTWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M1jVdmlEPTB;MUOuOlk6PCEQvF2= MUTTRW5ITVJ?
NCI-N87 NYHYS5J2T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MUHJR|UxRTF|LkezOkDPxE1? MV;TRW5ITVJ?
EB2 MlX2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MWfJR|UxRTF|Lki1NFUh|ryP NUjDSHo3W0GQR1XS
DB MY\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M4DKTmlEPTB;MUOuPVg5PSEQvF2= MX3TRW5ITVJ?
697 NWLsPWNVT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NEXT[5JKSzVyPUG0MlQ2OTFizszN NH\5bWpUSU6JRWK=
MSTO-211H M2nYXmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MkPuTWM2OD1zND63OFQ5KM7:TR?= M4XD[HNCVkeHUh?=
JVM-2 M3nOZ2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NVzWZnNZUUN3ME2xOE44PzN3IN88US=> NIrUTHdUSU6JRWK=
COLO-824 Mn[yS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NXPtOoFYUUN3ME2xOE44QTl2IN88US=> NE\3PINUSU6JRWK=
BC-3 NHfLZmxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NFPFOJNKSzVyPUG1MlM6QCEQvF2= MX;TRW5ITVJ?
BOKU MYrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NUHxTpFrUUN3ME2xOU46PjB6IN88US=> MmTRV2FPT0WU
GOTO MYTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NI\MdFhKSzVyPUG2Mlk3OTdizszN MmXXV2FPT0WU
HCC2157 NVHxU4JlT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M{XCemlEPTB;MUeuOFc2PSEQvF2= M{S1ZnNCVkeHUh?=
LS-1034 M2HUVWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M3ywPGlEPTB;MUeuOlgyQCEQvF2= MYnTRW5ITVJ?
CAL-148 NEfoTWNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MUHJR|UxRTF5Lkm3PVYh|ryP M{DGOXNCVkeHUh?=
MOLT-4 MnzNS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NFz3V4RKSzVyPUG4MlgzODhizszN MnHaV2FPT0WU
Daudi NVrmTGVoT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NEHGS3RKSzVyPUG4MlkzOzFizszN NXfVW4dXW0GQR1XS
J-RT3-T3-5 MUfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NF\UNHJKSzVyPUG5MlQxPjZizszN NVjMZnRSW0GQR1XS
KMOE-2 NVzvPYp5T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MlLFTWM2OD1zOT62OFgzKM7:TR?= MYXTRW5ITVJ?
HL-60 Mm\lS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M3;4ZWlEPTB;MkCuNVk3PSEQvF2= NYroWXd1W0GQR1XS
P31-FUJ NG\RZY1Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NHfrR5NKSzVyPUKwMlQ4PTNizszN MofCV2FPT0WU
IM-9 M2fBOWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MX3JR|UxRTJyLk[yNlQh|ryP NIO1bnBUSU6JRWK=
HDLM-2 MXjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NWO2XphoUUN3ME2yNE45QDJzIN88US=> MYLTRW5ITVJ?
NCI-H1304 NFTucoRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MYXJR|UxRTJzLkCzNVEh|ryP NIfUcYRUSU6JRWK=
NCI-H345 MmDmS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MV3JR|UxRTJzLkC2OFMh|ryP Ml;uV2FPT0WU
RPMI-6666 NV36WXExT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M3fObGlEPTB;MkGuN|YxOiEQvF2= MluxV2FPT0WU
GR-ST MnzhS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NH;LSZdKSzVyPUKxMlQyPyEQvF2= M3XrT3NCVkeHUh?=
CHP-126 NHPzNpFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NEfLcGxKSzVyPUKxMlYyQDFizszN MlTQV2FPT0WU
EHEB NGf4NYJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MonGTWM2OD1{MT62O|MyKM7:TR?= NXfBd4pPW0GQR1XS
CPC-N NEm0S4NIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M1nXbGlEPTB;MkSuNFIxOSEQvF2= M2PFbHNCVkeHUh?=
NB1 MXTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NXj2enNqUUN3ME2yOE43QTN7IN88US=> M2LD[XNCVkeHUh?=
LS-123 M3zscWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MoTLTWM2OD1{ND65NFEzKM7:TR?= MXjTRW5ITVJ?
ST486 MkPKS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NUnnVYtwUUN3ME2yOU4yOTF|IN88US=> M{DXO3NCVkeHUh?=
NCI-H1963 Ml3HS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M{XkeWlEPTB;Mk[uNFYzOyEQvF2= NES4UmlUSU6JRWK=
U-87-MG NH\pc2xIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MlzHTWM2OD1{Nj63OlQ1KM7:TR?= MUPTRW5ITVJ?
COR-L279 M2rufmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NYPpUoZyUUN3ME2yOk44QTJ{IN88US=> MUHTRW5ITVJ?
LU-165 MoLpS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NIDPRoVKSzVyPUK4MlA5PjFizszN MUXTRW5ITVJ?
COLO-800 NG[1XXlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NFfBZWNKSzVyPUK4MlI6PTZizszN NGXaT|NUSU6JRWK=
ETK-1 M3vHNGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MUPJR|UxRTJ6LkO0OFYh|ryP MUjTRW5ITVJ?
LNCaP-Clone-FGC MWXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MmnZTWM2OD1{OT65NlgyKM7:TR?= NUG5U|M1W0GQR1XS
SIG-M5 MVrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NFnudXpKSzVyPUOwMlc6PTJizszN M2jjN3NCVkeHUh?=
NB6 M33hNmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 Mnv5TWM2OD1|MD65OVA{KM7:TR?= MVrTRW5ITVJ?
NCI-H2107 M4nxb2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NF3SNHZKSzVyPUOxMlI{OzhizszN NIPRT|dUSU6JRWK=
SNU-C1 M{\kU2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NVfzWGpkUUN3ME2zNU4{OTJ4IN88US=> MlyyV2FPT0WU
JAR NXTLXYlKT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MXfJR|UxRTNzLkO3PVkh|ryP NWHvWXpNW0GQR1XS
L-363 NVHneY9YT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NV\ucWlYUUN3ME2zNk4zOTR2IN88US=> NF;Od4lUSU6JRWK=
EW-24 M4W1VWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M2L1T2lEPTB;M{KuN|Q4PCEQvF2= M3zodnNCVkeHUh?=
NB69 MmK2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NHnRd4dKSzVyPUOzMlY1PTRizszN M4TuRnNCVkeHUh?=
EW-13 NYfVWGg4T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MXHJR|UxRTN|Lki5Olkh|ryP NFLy[|NUSU6JRWK=
Ramos-2G6-4C10 MnzDS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MWrJR|UxRTN2LkK5PVMh|ryP NGfPRppUSU6JRWK=
TE-11 MUTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MoTtTWM2OD1|ND60PFIzKM7:TR?= NFj0OHZUSU6JRWK=
L-428 MUDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M4TkVWlEPTB;M{SuO|U{PiEQvF2= MkTzV2FPT0WU
KP-N-YN M1e3W2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MlfTTWM2OD1|ND65NFU4KM7:TR?= MVLTRW5ITVJ?
CGTH-W-1 NWezUGY3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MYDJR|UxRTN4LkmwOFgh|ryP M1vLWHNCVkeHUh?=
K-562 NYf1NlljT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M1H5R2lEPTB;M{euNFg3PCEQvF2= NV74S4hZW0GQR1XS
NCI-H1299 MYLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? Mn3UTWM2OD1|OD6xOlA{KM7:TR?= MYHTRW5ITVJ?
RCC10RGB MlzaS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M1XObGlEPTB;M{iuNlA5OyEQvF2= NIfRcVhUSU6JRWK=
NCI-SNU-16 M1GyV2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NWO5[lZzUUN3ME2zPE42PjV|IN88US=> NHrmTVNUSU6JRWK=
LC-2-ad MX;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M3n6TWlEPTB;M{muOFM{PyEQvF2= M3rRO3NCVkeHUh?=
MHH-PREB-1 M320XWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NE\VRmZKSzVyPUO5Mlc{QDhizszN M{\1eXNCVkeHUh?=
NCI-H64 M163TWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MYnJR|UxRTRyLkC5OFgh|ryP MnHrV2FPT0WU
LB996-RCC M4Xv[Wdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 Mn7KTWM2OD12MD64O|E3KM7:TR?= M{[3[nNCVkeHUh?=
DEL NYC2PWZJT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M2\IT2lEPTB;NEGuOFQxPSEQvF2= MoLEV2FPT0WU
MLMA M2\w[Wdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M4rXfGlEPTB;NEGuO|U6PSEQvF2= NVHYcZlvW0GQR1XS
SBC-1 NYG0bYFET3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NXPRc|JiUUN3ME20Nk4yQDB4IN88US=> MUjTRW5ITVJ?
MPP-89 NIPYPXBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MULJR|UxRTR{LkW4O|Uh|ryP NELWS2FUSU6JRWK=
MV-4-11 M1XhUmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NFTtSW5KSzVyPUSyMlkxPjdizszN NWPjeIFlW0GQR1XS
EoL-1- NHPrfIJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M333XWlEPTB;NESuNVU3QCEQvF2= NYrKUnQxW0GQR1XS
CW-2 MUHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MoD0TWM2OD12ND64N|QzKM7:TR?= MXPTRW5ITVJ?
HT NXvV[5FuT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M3nIfmlEPTB;NEWuO|AxPyEQvF2= NHzEUGZUSU6JRWK=
SW954 NV7zSJFpT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NIqzWmRKSzVyPUS3MlQyOjhizszN NWD1XZRlW0GQR1XS
A3-KAW MmrtS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MmL2TWM2OD12OT64NFYyKM7:TR?= NHLDN2JUSU6JRWK=
TC-YIK MWnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NHX1OFFKSzVyPUWwMlA{PjNizszN NVfteZZSW0GQR1XS
SW962 MnznS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NWrWcpJ7UUN3ME21OE45OzV5IN88US=> NXrQbHA1W0GQR1XS
KP-N-RT-BM-1 MmDNS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MlvpTWM2OD13Nj62OlM5KM7:TR?= NIPSXXdUSU6JRWK=
NCI-H1395 MXvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M2PMW2lEPTB;NUiuPFE4OiEQvF2= Mmr6V2FPT0WU
RPMI-8402 MXPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M3mwVmlEPTB;NUiuPVUzPiEQvF2= NV32e5N[W0GQR1XS
SCH NXvKTVZHT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MXjJR|UxRTZyLkm2N|gh|ryP MXrTRW5ITVJ?
NCI-H2196 NXu0UppxT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MWTJR|UxRTZzLkKzNUDPxE1? M4XvUHNCVkeHUh?=
LOXIMVI NILkSYhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NUXtXoM2UUN3ME22NU45OjZ4IN88US=> NYnFWZl{W0GQR1XS
TGBC24TKB MUPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NYj4V|VPUUN3ME22Nk4yPDlzIN88US=> NYXaXZNPW0GQR1XS
SK-MEL-2 MnrJS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NVXQNWJxUUN3ME22N{46QDl{IN88US=> MUfTRW5ITVJ?
U-698-M M1fmPGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 Mm\VTWM2OD14OD61Olg4KM7:TR?= M3T5TnNCVkeHUh?=
NCI-H1522 M3rEUGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NV[0PFFXUUN3ME22PU4xODR5IN88US=> M4PkcHNCVkeHUh?=
UACC-812 Ml[5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NInmOZhKSzVyPU[5MlUzODlizszN Mo\qV2FPT0WU
MHH-CALL-2 NVv2NmJGT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M4D5OWlEPTB;N{CuNFYh|ryP NEHsTlBUSU6JRWK=
NB5 MXvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MV3JR|UxRTdyLkO0Olgh|ryP MmjUV2FPT0WU
KARPAS-299 MWfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MVvJR|UxRTdyLkS0OFch|ryP MY\TRW5ITVJ?
NCI-H1694 Mk\RS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MXjJR|UxRTdzLkCzNkDPxE1? NWfq[GNNW0GQR1XS
NCI-H82 MoTRS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M2DJemlEPTB;N{GuPVUxPyEQvF2= NX\pd3czW0GQR1XS
SCC-15 MVnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NUS2d2FoUUN3ME23Nk4{PCEQvF2= NX3RN4J2W0GQR1XS
NCI-H1436 MXLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MXfJR|UxRTd{Lke0OVYh|ryP NE\ib|RUSU6JRWK=
ATN-1 M{H2Tmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NWHSZ406UUN3ME23OE42ODVizszN NG\ve5lUSU6JRWK=
RPMI-8866 M2rZUGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NF;YdmJKSzVyPUe0Mlc2ODlizszN MmfhV2FPT0WU
HCC1599 MVzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MmfLTWM2OD15ND64O|MzKM7:TR?= MUjTRW5ITVJ?
NCI-H1155 M4rOSWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NVzVb2c3UUN3ME23OE46OzZ5IN88US=> NXLKZphUW0GQR1XS
DOHH-2 NEnlOYtIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MYDJR|UxRTd2Lkm1NVQh|ryP NYfuNHV5W0GQR1XS
SK-NEP-1 MVvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M3LST2lEPTB;N{WuNFc2PCEQvF2= NEmxbo9USU6JRWK=
HCC1187 NXricGxjT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MX;JR|UxRTd5Lk[xNlIh|ryP M1i1O3NCVkeHUh?=
NCI-H322M NXLrfVJ4T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NFHZVVBKSzVyPUe4MlM4ODlizszN NEPqb5pUSU6JRWK=
NCI-H526 MU\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M4XZRmlEPTB;N{iuOVg4PyEQvF2= MXrTRW5ITVJ?
NCI-H2171 NVPkR2VRT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MmrzTWM2OD15OT60NVM3KM7:TR?= MX3TRW5ITVJ?
COLO-668 NW\tOGk5T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NWnDeGpUUUN3ME24NU42QDh2IN88US=> NYj1NJFPW0GQR1XS
RS4-11 NH\WcXpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M1ziWmlEPTB;OEKuNlUxPSEQvF2= MV\TRW5ITVJ?
NCI-H716 MonwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M2S0V2lEPTB;OEKuPVA4PSEQvF2= MkPvV2FPT0WU
LU-134-A MnizS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M{P0UmlEPTB;OEOuNVM2OSEQvF2= M{PzWHNCVkeHUh?=
RPMI-8226 M1\OW2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 Ml3YTWM2OD16ND6yNVA4KM7:TR?= MlHMV2FPT0WU
KY821 NGnnVHhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= Ml;oTWM2OD17MT62OVUyKM7:TR?= MmXQV2FPT0WU
ECC4 NHfqUYtIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NGTw[mdKSzVyPUmzMlgzPjlizszN M4TJZ3NCVkeHUh?=
EW-3 NWf5ZWZxT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NGTqcGhKSzVyPUm0MlkxQDFizszN MnjjV2FPT0WU
NB7 NHn4UmtIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NGXhSWFKSzVyPUm1Mlc4QDZizszN MVrTRW5ITVJ?
NCI-H720 NEPKNY9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M2HHfmlEPTB;OUiuOFA3OSEQvF2= M4nC[3NCVkeHUh?=
NCI-H446 MWXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M3fneWlEPTB;OUmuO|U5QCEQvF2= NHLQSYZUSU6JRWK=
NCI-H889 M2Cwemdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MXXJR|UxRTFyND6yOFIh|ryP M2L4RXNCVkeHUh?=
EW-22 MoP1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MWDJR|UxRTFyNj6xPUDPxE1? NF3lUnhUSU6JRWK=
BV-173 NHP4OWJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NUHNbodqUUN3ME2xNFgvPzJ6IN88US=> NUDCe3BVW0GQR1XS
WSU-NHL NIXu[WdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M4nHOGlEPTB;MUC5MlY4OSEQvF2= M2XKWHNCVkeHUh?=
MN-60 M1HzWGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MnP2TWM2OD1zMEmuOlkh|ryP NVPPXIs4W0GQR1XS
DG-75 Mki4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MYnJR|UxRTFzMz6zOVIh|ryP NVfqT452W0GQR1XS
DMS-79 MlnUS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NEXCNoxKSzVyPUGxO{4{QDJizszN NFPWbmZUSU6JRWK=
SK-MEL-1 MmXMS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MYDJR|UxRTFzOD6wNFkh|ryP NWH4dFNwW0GQR1XS
DMS-153 NXizN5FvT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MYnJR|UxRTF{MT63OFUh|ryP MojUV2FPT0WU
NCI-H510A NHzuSoJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NIqyeItKSzVyPUGyO{4{OiEQvF2= NIDIUnFUSU6JRWK=
BE-13 M3nzTGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MmLzTWM2OD1zM{SuNFQ1KM7:TR?= M3zscHNCVkeHUh?=
KP-N-YS NFvHWWhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M1vrWWlEPTB;MUO5Mlc{PiEQvF2= NVL2SJY2W0GQR1XS
SUP-T1 M3v5[2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NILueZRKSzVyPUG0N{44ODhizszN MWTTRW5ITVJ?
EW-12 NF\nXItIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MX;JR|UxRTF2ND62PVkh|ryP NI\acllUSU6JRWK=
NB14 NHHob|FIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MW\JR|UxRTF2Nz6wPFIh|ryP NWjycIxiW0GQR1XS
MDA-MB-134-VI M1vLXGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M2rPc2lEPTB;MUS4MlI3QCEQvF2= NIro[o1USU6JRWK=
NCI-H1770 MUXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? Ml3YTWM2OD1zNU[uNlc6KM7:TR?= NXTZbIJVW0GQR1XS
TUR M3rOWWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NX7kNmlCUUN3ME2xOlcvQDdizszN M2XSenNCVkeHUh?=
NCI-H1417 MnXSS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NIjQW2NKSzVyPUG4NE4{OzFizszN M{fZd3NCVkeHUh?=
IMR-5 M17ofGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M2TCcWlEPTB;MUixMlU4OSEQvF2= MVXTRW5ITVJ?
NCI-H226 NUDDcYRGT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MXHJR|UxRTF6OD64OlYh|ryP M13zNnNCVkeHUh?=
NCI-H187 MWDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NVfNXJh2UUN3ME2xPVAvODZ2IN88US=> MmjRV2FPT0WU
SF539 MnzCS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NXy1U5ZjUUN3ME2xPVIvPzJ6IN88US=> M{fsbXNCVkeHUh?=
TALL-1 NV\zPHJmT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MVjJR|UxRTF7OD6zNFQh|ryP NEjDc5pUSU6JRWK=
TE-441-T MVfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MWjJR|UxRTF7OT63N|kh|ryP Mm[3V2FPT0WU
REH M1rIeGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M3;vfWlEPTB;MkO2MlYzPiEQvF2= NFjxXI5USU6JRWK=
MS-1 MkD2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M3jlVWlEPTB;MkO5MlEzOSEQvF2= MnTDV2FPT0WU
THP-1 NVX5bGhuT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MVPJR|UxRTJ4ND63N|gh|ryP NYHjTJFMW0GQR1XS
NCI-H1838 MWLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NUjMUlJCUUN3ME2yO|EvPDV4IN88US=> M4DWVHNCVkeHUh?=
P30-OHK NGHSfZlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MWLJR|UxRTJ6Mz64OFch|ryP NWS5THlCW0GQR1XS
C8166 M4D5Smdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M4m3fGlEPTB;M{S1MlM{QCEQvF2= MVPTRW5ITVJ?

他の多くの細胞株試験データをご覧になる場合はこちらをクリックして下さい

体内試験 Administration of MG-132 effectively rescues the expression levels and plasma membrane localization of dystrophin, β-dystroglycan, α-bdystroglycan, and α-sarcoglycan in skeletal muscle fibers from mdx mice, reduces muscle membrane damage, and ameliorates the histopathological signs of muscular dystrophy. [7] MG-132 treatment significantly reduces immobilization-induced skeletal muscle atrophy in mice, by downregulating the muscle-specific ubiquitin ligases atrogin-1/MAFbx and MuRF-1 mRNA. [8]

お薦めの試験操作(参考用のみ)

キナーゼ試験:

[1]

+ 展開

Measurement of inhibitory activities of MG-132 against 20S proteasome:

The reaction mixture for the 20S proteasome inhibitory assay contains 0.1 M Tris-acetate, pH 7.0, 20S proteasome, MG-132, and 25 μM substrate dissolved in dimethyl sulfoxide in a final volume of 1 mL. After incuba tion at 37 °C for 15 minutes, the reaction is stopped by the addition of 0.1 mL of 10% SDS and 0.9 mL of 0.1M Tris acetate, pH 9.0. The fluorescence of the reaction products is measured. To determine the IC50 against 20S proteasome, various concentrations of MG-132 are included in the assay mixture.
細胞試験:

[3]

+ 展開
  • 細胞株: KIM-2, HC11, and ES
  • 濃度: Dissolved in DMSO, final concentrations ~25 μM
  • 反応時間: 24 and 48 hours
  • 実験の流れ:

    Cells are exposed to various concentrations of MG-132 for 24, and 48 hours. Supernatant and monolayer cells are harvested by centrifugation and fixed in 70% ethanol in PBS for staining with acridine orange. Equal volumes of cells and acridine orange (5 mg/mL in PBS) are mixed on a microscope slide and examined by fluorescence microscopy. For annexin V analysis, cells are harvested by centrifugation and stained with annexin V and propidium iodide. For cell cycle analysis, cells are rehydrated in PBS at room temperature for 10 minutes, followed by staining with propidium iodide (5 mg/mL). All samples are analyzed using a Coulter Epics XL flow cytometer.


    (参考用のみ)
動物試験:

[7]

+ 展開
  • 動物モデル: Male mdx (C57BL/10ScSn DMD mdx) mice
  • 製剤: Dissolved in DMSO, and diluted in PBS
  • 投薬量: ~10 μg/kg/day
  • 投与方法: Injection
    (参考用のみ)

溶解度 (25°C)

体外 DMSO 90 mg/mL (189.22 mM)
Ethanol 25 mg/mL (52.56 mM)
Water Insoluble
体内 左から(NMPから)右の順に溶剤を製品に加えます(文献ではなく、Selleckの実験によるデータ):
4% DMSO+30% PEG 300+20% propylene glycol+ddH2O
混合させたのち直ちに使用することを推奨します。
2mg/mL

* 溶解度測定はSelleck技術部門によって行われており、その他文献に示されている溶解度と差異がある可能性がありますが、同一ロットの生産工程で起きる正常な現象ですからご安心ください。

化学情報

分子量 475.62
化学式

C26H41N3O5

CAS No. 133407-82-6
保管
in solvent
別名 N/A

便利ツール

モル濃度計算器

モル濃度計算器

求めたい質量、体積または濃度を計算してください。

質量 (g) = 濃度 (mol/L) x 体積 (L) x 分子量 (g/mol)

モル濃度計算器方程式

  • 質量
    濃度
    体積
    分子量

*貯蔵液を準備するとき、常に、オンであるとわかる製品のバッチに特有の分子量を使って、を通してラベルとMSDS/COA(製品ページで利用可能な)。

希釈計算器

希釈計算器

貯蔵液を準備するために必要な希釈率を計算してください。Selleck希釈計算器は、以下の方程式に基づきます:

開始濃度 x 開始体積 = 最終濃度 x 最終体積

希釈の計算式

この方程式は、一般に略語を使われます:C1V1 = C2V2 ( 入力 出力 )

  • C1
    V1
    C2
    V2

常に貯蔵液を準備するとき、小びんラベルとMSDS/COA(オンラインで利用できる)で見つかる製品のバッチに特有の分子量を使ってください。

連続希釈計算器方程式

  • 連続希釈剤

  • 計算結果

  • C1=C0/X C1: LOG(C1):
    C2=C1/X C2: LOG(C2):
    C3=C2/X C3: LOG(C3):
    C4=C3/X C4: LOG(C4):
    C5=C4/X C5: LOG(C5):
    C6=C5/X C6: LOG(C6):
    C7=C6/X C7: LOG(C7):
    C8=C7/X C8: LOG(C8):
分子量計算器

分子量计算器

そのモル質量と元素組成を計算するために、合成物の化学式を入力してください:

総分子量:g/mol

チップス: 化学式は大文字と小文字の区別ができます。C10H16N2O2 c10h16n2o2

モル濃度計算器

質量 濃度 体積 分子量

技術サポート

ストックの作り方、阻害剤の保管方法、細胞実験や動物実験の際に注意すべき点など、製品を取扱う時に問い合わせが多かった質問に対しては取扱説明書でお答えしています。

Handling Instructions

他に質問がある場合は、お気軽にお問い合わせください。

  • * 必須

よくある質問(FAQ)

  • 質問1:

    I want to know whether it contains EDTA or other chelating agent in this product(S2619)?

  • 回答:

    Our S2619 MG-132 doesn't contain EDTA or other chelating agent.

Proteasomeシグナル伝達経路

Proteasome Inhibitors with Unique Features

相関Proteasome製品

Tags: MG-132を買う | MG-132 ic50 | MG-132供給者 | MG-132を購入する | MG-132費用 | MG-132生産者 | オーダーMG-132 | MG-132化学構造 | MG-132分子量 | MG-132代理店
×
細胞株 試験類型 濃度 培養時間 溶剤類型 活性叙述 PMID